Every year, the parasite **Entamoeba histolytica** is responsible for approximately **50 million infections** and **70,000 deaths** worldwide.
This single-celled organism, the cause of **amoebiasis**, has developed a remarkable survival strategy: it disguises itself using fragments of human cells to evade the immune system.
A Microscopic Chameleon
Unlike other pathogens, E. histolytica doesn’t just invade the human body—it uses a process called **trogocytosis** to steal pieces of host cells and incorporate them onto its surface.
This biological camouflage allows it to **trick the immune system**, making it appear as a normal human cell and avoiding detection.
Damage and Spread
Amoebiasis can cause mild symptoms like diarrhea, but in severe cases, it leads to **tissue destruction** in the colon, liver, and even the brain.
Transmission occurs mainly through **contaminated food and water**, making the disease particularly prevalent in regions with poor sanitation.
The Challenge of Research
Scientists are studying the complex genome of E. histolytica to develop **new treatments and vaccines**. With advanced genetic tools like **CRISPR**, researchers hope to create targeted therapies to combat this stealthy parasite.
Entamoeba histolytica is a silent but deadly threat. Ongoing research continues to uncover its secrets, aiming to reduce infections and save lives. The fight against this parasite is far from over, but science is determined to win.